Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 62, Issue 19, 2005, Pages 1998-2000

  Xu, Quanyun A ^a   Trissel, Lawrence A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antiemetics; Antineoplastic agents; Cyclophosphamide; Ifosfamide; Incompatibilities; Injections; Palonosetron hydrochloride; Particle size; Stability; Storage; Turbidity

Indexed keywords

CYCLOPHOSPHAMIDE; IFOSFAMIDE; PALONOSETRON;

ARTICLE; CONCENTRATION RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG INCOMPATIBILITY; DRUG STABILITY; EVALUATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL; SIMULATION; TURBIDIMETRY;

EID: 26244449693     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040275     Document Type: Article

References (7)

1. Aloxi package insert. Bloomington, MN: MGI Pharma; 2003 Jul.
2. Stacher G. Palonosetron (Helsinn). Curr Opin Investig Drugs. 2002; 3:1502-7.
3. Eglen RM, Lee CH, Smith WL et al. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo. Br J Pharmacol 1995; 114:860-6.
4. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
5. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm. 1992; 49:1716-9.
6. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm. 1993; 50:300-4.
7. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm. 1993; 50:2359-63.